| Reference |
|---|
Li J, Liu J, Wei C, Liu X, Lin S, Wu C. Hydrogel-Gated MXene-Graphene Field-Effect Transistor for Selective Detection and Screening of SARS-CoV-2 and E. coli Bacteria. ACS Appl Mater Interfaces. 2025;17:2871-2883 pubmed publisher |
van Ewijk C, Su xe1 rez Hern xe1 ndez S, Jacobi R, Knol M, Hahn xe9 S, Wijmenga Monsuur A, et al. Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity. Vaccine X. 2025;22:100593 pubmed publisher |
van de Garde M, Miranda Bedate A, Nanlohy N, Jacobi R, Meijer A, Reukers D, et al. Early immune profiling reveals distinct inflammatory responses between children and adults few days after primary SARS-CoV-2 infection. Front Immunol. 2024;15:1359993 pubmed publisher |
Shang J, Li H, Liu X, Sun S, Huan S, Xiong B. Single-particle rotational sensing for analyzing the neutralization activity of antiviral antibodies. Talanta. 2024;279:126606 pubmed publisher |
Li J, Hsu K, Howe S, Hoang T, Xia Z, Berzofsky J, et al. Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice. Front Immunol. 2024;15:1386243 pubmed publisher |
Jansen E, Ostadgavahi A, Hewins B, Buchanan R, Thivierge B, Sganzerla Martinez G, et al. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females. Sci Rep. 2024;14:9854 pubmed publisher |
Kinoshita M, Muranishi K, Kawaguchi K, Sudo K, Inoue K, Ishikura H, et al. Immunological Response to Subcutaneous and Intranasal Administration of SARS-CoV-2 Spike Protein in Mice. Vaccines (Basel). 2024;12: pubmed publisher |
Liu S, Chen H, Chen X, Luo N, Peraramelli S, Gong X, et al. Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection. Front Immunol. 2024;15:1365803 pubmed publisher |
V xe1 squez V, Orozco J. Clinical validation of SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex. J Virol Methods. 2024;327:114940 pubmed publisher |
Verheul M, Kaczorowska J, Hofstee M, Schepp R, Smits G, Wessels Beljaars D, et al. Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands. Mucosal Immunol. 2024;17:554-564 pubmed publisher |
Park C, Hwang I, Yan S, Vimonpatranon S, Wei D, Van Ryk D, et al. Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage. elife. 2024;12: pubmed publisher |
Adachi T, Nakamura S, Michishita A, Kawahara D, Yamamoto M, Hamada M, et al. RaptGen-Assisted Generation of an RNA/DNA Hybrid Aptamer against SARS-CoV-2 Spike Protein. Biochemistry. 2024;63:906-912 pubmed publisher |
Zhou F, Vahokoski J, Langeland N, Cox R. Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. NPJ Vaccines. 2024;9:37 pubmed publisher |
Sui Y, Andersen H, Li J, Hoang T, Minai M, Nagata B, et al. SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy. Vaccine. 2024;42:339-351 pubmed publisher |
Aksu M, Kumar P, G xfc ttler T, Taxer W, Gregor K, Mu xdf il B, et al. Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral Res. 2024;221:105778 pubmed publisher |
Almaz xe1 n N, Rahbar A, Carlsson M, Hoffman T, Kolstad L, R xf6 nnberg B, et al. Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics. iScience. 2023;26:108441 pubmed publisher |
Heo C, Lim W, Yang J, Son S, Kim S, Kim D, et al. Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern. Front Immunol. 2023;14:1307693 pubmed publisher |
Jiang S, Qian S, Zhu S, Lu J, Hu Y, Zhang C, et al. A Point-of-Care Testing Device Utilizing Graphene-Enhanced Fiber Optic SPR Sensor for Real-Time Detection of Infectious Pathogens. Biosensors (Basel). 2023;13: pubmed publisher |
Yu B, Drelich A, Hsu J, Tat V, Peng B, Wei Q, et al. Protective Efficacy of Novel Engineered Human ACE2-Fc Fusion Protein Against Pan-SARS-CoV-2 Infection In Vitro and in Vivo. J Med Chem. 2023;66:16646-16657 pubmed publisher |
Li H, Gong H, Wong T, Zhou J, Wang Y, Lin L, et al. Wireless, battery-free, multifunctional integrated bioelectronics for respiratory pathogens monitoring and severity evaluation. Nat Commun. 2023;14:7539 pubmed publisher |
Li L, Chiu H, Wong W, Huang K, Lin T, Chen S, et al. Antrodia cinnamomea May Interfere with the Interaction Between ACE2 and SARS-CoV-2 Spike Protein in vitro and Reduces Lung Inflammation in a Hamster Model of COVID-19. J Inflamm Res. 2023;16:4867-4884 pubmed publisher |
Kim L, Jo S, Kim G, Kim K, Seo S, Ryu E, et al. Recombinant protein embedded liposome on gold nanoparticle based on LSPR method to detect Corona virus. Nano Converg. 2023;10:51 pubmed publisher |
Zhang P, Luo S, Zou P, Deng Q, Wang C, Li J, et al. A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens. Microbiol Spectr. 2023;11:e0179423 pubmed publisher |
Duerr R, Dimartino D, Marier C, Zappile P, Wang G, Fran xe7 ois F, et al. Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational study. EBioMedicine. 2023;97:104843 pubmed publisher |
Machado R, Walker J, Scharton D, Rafael G, Mitchell B, Reyna R, et al. Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters. Nat Commun. 2023;14:4260 pubmed publisher |
Villa Manso A, Guerrero Esteban T, Pariente F, Toyos Rodr xed guez C, de la Escosura Mu xf1 iz A, Revenga Parra M, et al. Bifunctional Au@Pt/Au nanoparticles as electrochemiluminescence signaling probes for SARS-CoV-2 detection. Talanta. 2023;260:124614 pubmed publisher |
Li L, Zhao Z, Yang X, Su Z, Li W, Chen S, et al. A Newly Identified Spike Protein Targeted Linear B-Cell Epitope Based Dissolvable Microneedle Array Successfully Eliciting Neutralizing Activities against SARS-CoV-2 Wild-Type Strain in Mice. Adv Sci (Weinh). 2023;10:e2207474 pubmed publisher |
Adams L, Leist S, Dinnon K, West A, Gully K, Anderson E, et al. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination. Cell Rep. 2023;42:112326 pubmed publisher |
Park K, Choi A, Kim H, Park I, Eom M, Yeo S, et al. Ultra-sensitive label-free SERS biosensor with high-throughput screened DNA aptamer for universal detection of SARS-CoV-2 variants from clinical samples. Biosens Bioelectron. 2023;228:115202 pubmed publisher |
Jia T, Wu Y, Liao G, Lei Y, Wu Z, Yang F, et al. Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine. J Med Virol. 2023;95:e28662 pubmed publisher |
Ouyang Y, Chen Y, Shang J, Sun S, Wang X, Huan S, et al. Virus-like Plasmonic Nanoprobes for Quick Analysis of Antiviral Efficacy and Mutation-Induced Drug Resistance. Anal Chem. 2023;95:5009-5017 pubmed publisher |
Zhou S, Zhang R, You Z, Zou Y, Wen Y, Wang J, et al. pH-Sensitive and Biodegradable Mn3(PO4)2·3H2O Nanoparticles as an Adjuvant of Protein-Based Bivalent COVID-19 Vaccine to Induce Potent and Broad-Spectrum Immunity. ACS Appl Mater Interfaces. 2023;: pubmed publisher |
Seo S, Ryu E, Kim J, Shin C, Kwon O. Fluorophore-encapsulated nanobeads for on-site, rapid, and sensitive lateral flow assay. Sens Actuators B Chem. 2023;381:133364 pubmed publisher |
Norris E, Pan X, Hocking D. Receptor-binding domain of SARS-CoV-2 is a functional αv-integrin agonist. J Biol Chem. 2023;299:102922 pubmed publisher |
Yang Y, Xing H, Zhao Y. Transplacental transmission of SARS-CoV-2 immunoglobulin G antibody to infants from maternal COVID-19 vaccine immunization before pregnancy. J Med Virol. 2023;95:e28296 pubmed publisher |
Samanovic M, Oom A, Cornelius A, Gray Gaillard S, Karmacharya T, Tuen M, et al. Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines. Vaccines (Basel). 2022;10: pubmed publisher |
Langel S, Garrido C, Phan C, Travieso T, Kirshner H, DeMarco T, et al. Dam-Infant Rhesus Macaque Pairs to Dissect Age-Dependent Responses to SARS-CoV-2 Infection. Immunohorizons. 2022;6:851-863 pubmed publisher |
Wasfi A, Awwad F, Qamhieh N, Al Murshidi B, Palakkott A, GELOVANI J. Real-time COVID-19 detection via graphite oxide-based field-effect transistor biosensors decorated with Pt/Pd nanoparticles. Sci Rep. 2022;12:18155 pubmed publisher |
Zargartalebi H, Yousefi H, Flynn C, Gomis S, Das J, Young T, et al. Capillary-Assisted Molecular Pendulum Bioanalysis. J Am Chem Soc. 2022;144:18338-18349 pubmed publisher |
Wang B, Yang D, Chang Z, Zhang R, Dai J, Fang Y. Wearable bioelectronic masks for wireless detection of respiratory infectious diseases by gaseous media. Matter. 2022;5:4347-4362 pubmed publisher |
Jia L, Weng S, Wu J, Tian X, Zhang Y, Wang X, et al. Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity. Gut Microbes. 2022;14:2117503 pubmed publisher |
Karunakaran V, Joseph M, Yadev I, Sharma H, Shamna K, Saurav S, et al. A non-invasive ultrasensitive diagnostic approach for COVID-19 infection using salivary label-free SERS fingerprinting and artificial intelligence. J Photochem Photobiol B. 2022;234:112545 pubmed publisher |
Chen R, Xie H, Khorsandzadeh S, Smith M, Shaabani N, Hu Q, et al. Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2. J Mol Cell Biol. 2022;14: pubmed publisher |
Zhang P, Luo S, Zou P, Liang C, Wang C, Li J, et al. Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2. Mol Ther Methods Clin Dev. 2022;26:181-190 pubmed publisher |
Zimmerman O, Altman Doss A, Kaplonek P, Liang C, Vanblargan L, Chen R, et al. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes. Cell Rep Med. 2022;3:100653 pubmed publisher |
Tzeng T, Chai K, Shen K, Yu C, Yang S, Huang W, et al. A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection. NPJ Vaccines. 2022;7:60 pubmed publisher |
Li W, Kitsios G, Bain W, Wang C, Li T, Fanning K, et al. Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients. mSystems. 2022;7:e0005822 pubmed publisher |
Norris E, Pan X, Hocking D. Receptor binding domain of SARS-CoV-2 is a functional αv-integrin agonist. bioRxiv. 2022;: pubmed publisher |
Walters J, Schouest B, Patel A, Reuschel E, Schultheis K, Parzych E, et al. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates. Vaccine. 2022;40:2960-2969 pubmed publisher |
Uprichard S, O Brien A, Evdokimova M, Rowe C, Joyce C, Hackbart M, et al. Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals. Viruses. 2022;14: pubmed publisher |
Kim J, Jeong S, Sarawut S, Kim H, Son S, Lee S, et al. An immunosensor based on a high performance dual-gate oxide semiconductor thin-film transistor for rapid detection of SARS-CoV-2. Lab Chip. 2022;22:899-907 pubmed publisher |
Wang X, Sanborn M, Dai Y, Rehman J. Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19. JCI Insight. 2022;7: pubmed publisher |
Liu J, Lu F, Chen Y, Plow E, Qin J. Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2. J Biol Chem. 2022;298:101710 pubmed publisher |
Yuan T, Garg P, Wang L, Willis J, Kwan E, Hernandez A, et al. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries. MAbs. 2022;14:2002236 pubmed publisher |
Feng Y, Zhang Y, He Z, Huang H, Tian X, Wang G, et al. Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study. EClinicalMedicine. 2022;43:101226 pubmed publisher |
Zamzami M, Rabbani G, Ahmad A, Basalah A, Al Sabban W, Nate Ahn S, et al. Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1. Bioelectrochemistry. 2022;143:107982 pubmed publisher |
Han H, Wang C, Yang X, Zheng S, Cheng X, Liu Z, et al. Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor. Sens Actuators B Chem. 2022;351:130897 pubmed publisher |
Cunningham J, Virhammar J, R xf6 nnberg B, Dopico X, Kolstad L, Albinsson B, et al. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms. J Infect Dis. 2022;225:965-970 pubmed publisher |
Emeribe A, Abdullahi I, Shuwa H, Uzairue L, Musa S, Anka A, et al. Humoral immunological kinetics of severe acute respiratory syndrome coronavirus 2 infection and diagnostic performance of serological assays for coronavirus disease 2019: an analysis of global reports. Int Health. 2022;14:18-52 pubmed publisher |
Sim K, Ko G, Bae S, Choi K, Lee J, Kim B, et al. Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection. Front Immunol. 2021;12:813240 pubmed publisher |
Mast F, Fridy P, Ketaren N, Wang J, Jacobs E, Olivier J, et al. Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. elife. 2021;10: pubmed publisher |
Royal J, Simpson C, McCormick A, Phillips A, Hume S, Morton J, et al. Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Vaccines (Basel). 2021;9: pubmed publisher |
Puligedda R, Al Saleem F, Wirblich C, Kattala C, Jovic M, Geiszler L, et al. A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue. Diagnostics (Basel). 2021;11: pubmed publisher |
Rabbani G, Ahn S, Kwon H, Ahmad K, Choi I. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein. Biochem Biophys Rep. 2021;28:101170 pubmed publisher |
Ren W, Lan J, Ju X, Gong M, Long Q, Zhu Z, et al. Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption. PLoS Pathog. 2021;17:e1010053 pubmed publisher |
Verma A, Hawes C, Lakshmanappa Y, Roh J, Schmidt B, Dutra J, et al. Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation. Cell Rep. 2021;37:109942 pubmed publisher |
Shin H, Ku K, Kim H, Moon H, Jeong G, Hwang I, et al. Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung. Int J Biol Sci. 2021;17:3786-3794 pubmed publisher |
Kong D, Wang X, Gu C, Guo M, Wang Y, Ai Z, et al. Direct SARS-CoV-2 Nucleic Acid Detection by Y-Shaped DNA Dual-Probe Transistor Assay. J Am Chem Soc. 2021;143:17004-17014 pubmed publisher |
Langellotto F, Dellacherie M, Yeager C, Ijaz H, Yu J, Cheng C, et al. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens. Adv Healthc Mater. 2021;10:e2101370 pubmed publisher |
Kramer K, Johnson N, Shiakolas A, Suryadevara N, Periasamy S, Raju N, et al. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell Rep. 2021;37:109784 pubmed publisher |
Nassir N, Tambi R, Bankapur A, Al Heialy S, Karuvantevida N, Khansaheb H, et al. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19. iScience. 2021;24:103030 pubmed publisher |
Camacho Sandoval R, Nieto Patl xe1 n A, Carballo Uicab G, Montes Luna A, Jim xe9 nez Mart xed nez M, Vallejo Castillo L, et al. Development and Evaluation of a Set of Spike and Receptor Binding Domain-Based Enzyme-Linked Immunosorbent Assays for SARS-CoV-2 Serological Testing. Diagnostics (Basel). 2021;11: pubmed publisher |
Cho B, Gautam S, Peng W, Huang Y, Goli M, Mechref Y. Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2. J Proteome Res. 2021;20:4357-4365 pubmed publisher |
Guttler T, Aksu M, Dickmanns A, Stegmann K, Gregor K, Rees R, et al. Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. EMBO J. 2021;40:e107985 pubmed publisher |
Lopez E, Haycroft E, Adair A, Mordant F, O Neill M, Pymm P, et al. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021;6: pubmed publisher |
Super M, Doherty E, Cartwright M, Seiler B, Langellotto F, Dimitrakakis N, et al. Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock. Nat Biomed Eng. 2021;: pubmed publisher |
Garrido C, Hurst J, Lorang C, Aquino J, Rodriguez J, Pfeiffer T, et al. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents. JCI Insight. 2021;6: pubmed publisher |
Yue J, Jin W, Yang H, Faulkner J, Song X, Qiu H, et al. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer. Front Mol Biosci. 2021;8:649575 pubmed publisher |
Li Z, Wang Z, Dinh P, Zhu D, Popowski K, Lutz H, et al. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat Nanotechnol. 2021;16:942-951 pubmed publisher |
Garrido C, Curtis A, Dennis M, Pathak S, Gao H, Montefiori D, et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Sci Immunol. 2021;6: pubmed publisher |
Liv L. Electrochemical immunosensor platform based on gold-clusters, cysteamine and glutaraldehyde modified electrode for diagnosing COVID-19. Microchem J. 2021;168:106445 pubmed publisher |
Bojadzic D, Alcazar O, Chen J, Chuang S, Condor Capcha J, Shehadeh L, et al. Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. ACS Infect Dis. 2021;7:1519-1534 pubmed publisher |
Fu D, Zhang G, Wang Y, Zhang Z, Hu H, Shen S, et al. Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes. PLoS Biol. 2021;19:e3001209 pubmed publisher |
Golden J, Zeng X, Cline C, Garrison A, White L, Fitzpatrick C, et al. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. J Gen Virol. 2021;102: pubmed publisher |
Sui Y, Li J, Zhang R, Prabhu S, Andersen H, Venzon D, et al. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques. JCI Insight. 2021;6: pubmed publisher |
Yuen R, Steiner D, Pihl R, Chavez E, Olson A, Smith E, et al. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021;12:614676 pubmed publisher |
Mast F, Fridy P, Ketaren N, Wang J, Jacobs E, Olivier J, et al. Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2. bioRxiv. 2021;: pubmed publisher |
Wang C, Wang S, Li D, Chen P, Han S, Zhao G, et al. Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone. ACS Infect Dis. 2021;7:1545-1554 pubmed publisher |
Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed publisher |
Bertoglio F, Meier D, Langreder N, Steinke S, Rand U, Simonelli L, et al. SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface. Nat Commun. 2021;12:1577 pubmed publisher |
Gao L, Zhou J, Yang S, Wang L, Chen X, Yang Y, et al. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity. Signal Transduct Target Ther. 2021;6:113 pubmed publisher |
Bao L, Song Z, Xue J, Gao H, Liu J, Wang J, et al. Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats. J Infect Dis. 2021;223:1313-1321 pubmed publisher |
Shao W, Shurin M, Wheeler S, He X, Star A. Rapid Detection of SARS-CoV-2 Antigens Using High-Purity Semiconducting Single-Walled Carbon Nanotube-Based Field-Effect Transistors. ACS Appl Mater Interfaces. 2021;13:10321-10327 pubmed publisher |
Daniloski Z, Jordan T, Ilmain J, Guo X, Bhabha G, tenOever B, et al. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types. elife. 2021;10: pubmed publisher |
Bojadzic D, Alcazar O, Buchwald P. Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19. Front Pharmacol. 2020;11:600372 pubmed publisher |
Sasisekharan V, Pentakota N, Jayaraman A, Tharakaraman K, Wogan G, Narayanasami U. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher |
Zeng Q, Li Y, Dong S, Chen Z, Gao X, Zhang H, et al. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol. 2020;11:596684 pubmed publisher |
Drouot L, Hantz S, Jouen F, Velay A, Lamia B, Veber B, et al. Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay. Front Microbiol. 2020;11:603931 pubmed publisher |
Rappazzo C, Tse L, Kaku C, Wrapp D, Sakharkar M, Huang D, et al. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19. bioRxiv. 2020;: pubmed publisher |
Wang C, Yang X, Gu B, Liu H, Zhou Z, Shi L, et al. Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads. Anal Chem. 2020;92:15542-15549 pubmed publisher |
Haun B, Lai C, Williams C, Wong T, Lieberman M, Pessaint L, et al. CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization. Front Immunol. 2020;11:599587 pubmed publisher |
Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, et al. Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell. 2020;183:1496-1507.e16 pubmed publisher |
Liu T, Hsiung J, Zhao S, Kost J, Sreedhar D, Hanson C, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates. Nat Biomed Eng. 2020;4:1188-1196 pubmed publisher |
Wang D, Baudys J, Bundy J, Solano M, Keppel T, Barr J. Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry. Anal Chem. 2020;92:14730-14739 pubmed publisher |
Torrente Rodríguez R, Lukas H, Tu J, Min J, Yang Y, Xu C, et al. SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring. Matter. 2020;3:1981-1998 pubmed publisher |
Sohn K, Lee S, Kim H, Cheon S, Jeong H, Lee J, et al. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis. J Korean Med Sci. 2020;35:e343 pubmed publisher |
Hassan A, Kafai N, Dmitriev I, Fox J, Smith B, Harvey I, et al. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020;183:169-184.e13 pubmed publisher |
Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, et al. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. Signal Transduct Target Ther. 2020;5:180 pubmed publisher |
Gorshkov K, Susumu K, Chen J, Xu M, Pradhan M, Zhu W, et al. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis. ACS Nano. 2020;14:12234-12247 pubmed publisher |
den Hartog G, Schepp R, Kuijer M, Geurtsvankessel C, van Beek J, Rots N, et al. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence. J Infect Dis. 2020;222:1452-1461 pubmed publisher |
Deng W, Bao L, Liu J, Xiao C, Liu J, Xue J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369:818-823 pubmed publisher |
Ravichandran S, Coyle E, Klenow L, Tang J, Grubbs G, Liu S, et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Sci Transl Med. 2020;12: pubmed publisher |
Smith T, Patel A, Ramos S, Elwood D, Zhu X, Yan J, et al. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020;11:2601 pubmed publisher |
Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, et al. Identification of Human Single-Domain Antibodies against SARS-CoV-2. Cell Host Microbe. 2020;27:891-898.e5 pubmed publisher |
Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-948 pubmed publisher |
Seo G, Lee G, Kim M, Baek S, Choi M, Ku K, et al. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor. ACS Nano. 2020;14:5135-5142 pubmed publisher |
. Nutrients in wheat, flour, and bread. Nutr Rev. 1967;25:118-21 pubmed |
Navr xe1 til J, Bednar xed k B. [Experience in the surgical treatment of ventricular septal defects]. Bratisl Lek Listy. 1966;46:513-22 pubmed |
Traissac F, Paccalin J. [A therapeutic problem. Digestive complications during anticoagulant treatment]. J Med Bord. 1966;143:1479-88 pubmed |
Kuwabara Y. [Keratotransplantation and contact lenses]. Kaiin Dayori Nihon Kontakuto Renzu Gakkai. 1966;8:155-63 pubmed |
Senger W. [Cullen's theory of neurosis]. Ned Tijdschr Geneeskd. 1967;111:30-2 pubmed |
